Involvement	O
of	O
Egr-1	B-protein
/RelA	B-protein
synergy	O
in	O
distinguishing	O
T	O
cell	O
activation	O
from	O
tumor	B-protein
necrosis	I-protein
factor-alpha	I-protein
-induced	O
NF-kappa	B-protein
B1	I-protein
transcription	O
.	O

NF-kappa	B-protein
B	I-protein
is	O
an	O
important	O
transcription	B-protein
factor	I-protein
required	O
for	O
T	O
cell	O
proliferation	O
and	O
other	O
immunological	O
functions	O
.	O

The	O
NF-kappa	B-DNA
B1	I-DNA
gene	I-DNA
encodes	O
a	O
105-kD	B-protein
protein	I-protein
that	O
is	O
the	O
precursor	O
of	O
the	O
p50	B-protein
component	I-protein
of	O
NF-kappa	B-protein
B	I-protein
.	O

Previously	O
,	O
we	O
and	O
others	O
have	O
demonstrated	O
that	O
NF-kappa	B-protein
B	I-protein
regulates	O
the	O
NF-kappa	B-DNA
B1	I-DNA
gene	I-DNA
.	O

In	O
this	O
manuscript	O
we	O
have	O
investigated	O
the	O
molecular	O
mechanisms	O
by	O
which	O
T	B-cell_line
cell	I-cell_line
lines	I-cell_line
stimulated	O
with	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
)	O
and	O
phytohemagglutin	B-protein
(	O
PHA	B-protein
)	O
display	O
significantly	O
higher	O
levels	O
of	O
NF-kappa	B-protein
B1	I-protein
encoding	O
transcripts	B-RNA
than	O
cells	O
stimulated	O
with	O
tumor	B-protein
necrosis	I-protein
factor-alpha	I-protein
,	O
despite	O
the	O
fact	O
that	O
both	O
stimuli	O
activate	O
NF-kappa	B-protein
B	I-protein
.	O

Characterization	O
of	O
the	O
NF-kappa	B-DNA
B1	I-DNA
promoter	I-DNA
identified	O
an	O
Egr-1	B-DNA
site	I-DNA
which	O
was	O
found	O
to	O
be	O
essential	O
for	O
both	O
the	O
PMA/	O
PHA	B-protein
-mediated	O
induction	O
as	O
well	O
as	O
the	O
synergistic	O
activation	O
observed	O
after	O
the	O
expression	O
of	O
the	O
RelA	O
subunit	O
of	O
NF-kappa	B-protein
B	I-protein
and	O
Egr-1	B-protein
.	O

Furthermore	O
,	O
Egr-1	B-protein
induction	O
was	O
required	O
for	O
endogenous	O
NF-kappa	B-DNA
B1	I-DNA
gene	O
expression	O
,	O
since	O
PMA/	O
PHA-stimulated	B-cell_line
T	I-cell_line
cell	I-cell_line
lines	I-cell_line
expressing	O
antisense	O
Egr-1	B-RNA
RNA	I-RNA
were	O
inhibited	O
in	O
their	O
ability	O
to	O
upregulate	O
NF-kappa	O
B1	O
transcription	O
.	O

Our	O
studies	O
indicate	O
that	O
transcriptional	O
synergy	O
mediated	O
by	O
activation	O
of	O
both	O
Egr-1	B-protein
and	O
NF-kappa	B-protein
B	I-protein
may	O
have	O
important	O
ramifications	O
in	O
T	O
cell	O
development	O
by	O
upregulating	O
NF-kappa	B-DNA
B1	I-DNA
gene	O
expression	O
.	O

Involvement	NULL
of	NULL
Egr-1/	NULL
RelA	NULL
Synergy	NULL
in	NULL
Distinguishing	NULL
T	NULL
Cell	NULL
Activation	NULL
from	NULL
Tumor	NULL
Necrosis	NULL
Factor-	NULL
«	NULL
-induced	NULL
NF-	NULL
«	NULL
kBI	NULL
Transcription	NULL
By	NULL
Patricia	NULL
C.	NULL
Cogswell	NULL
,	NULL
*	NULL
Marty	NULL
W.	NULL
Mayo	NULL
,	NULL
*	NULL
and	NULL
Albert	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.*	NULL
#	NULL
From	NULL
the	NULL
*	NULL
Lineberger	NULL
Comprehensive	NULL
C	NULL
ancer	NULL
C	NULL
enter	NULL
;	NULL
and	NULL
*Department	NULL
of	NULL
Biology	NULL
,	NULL
University	NULL
of	NULL
North	NULL
Carolina	NULL
,	NULL
Chapel	NULL
Hill	NULL
,	NULL
N	NULL
orth	NULL
Carolina	NULL
27599-7295	NULL
Sum	NULL
m	NULL
ary	NULL
NF-KB	NULL
is	NULL
an	NULL
important	NULL
transcription	NULL
factor	NULL
required	NULL
for	NULL
T	NULL
cell	NULL
proliferation	NULL
and	NULL
other	NULL
immuno-logical	NULL
functions	NULL
.	NULL

The	NULL
gene	NULL
encodes	NULL
a	NULL
105-kD	NULL
protein	NULL
that	NULL
is	NULL
the	NULL
precursor	NULL
of	NULL
the	NULL
p50	NULL
component	NULL
of	NULL
NF-kB	NULL
.	NULL

Previously	NULL
,	NULL
we	NULL
and	NULL
others	NULL
have	NULL
demonstrated	NULL
that	NULL
NF-KB	NULL
regulates	NULL
the	NULL
gene	NULL
.	NULL

In	NULL
this	NULL
manuscript	NULL
we	NULL
have	NULL
investigated	NULL
the	NULL
molecular	NULL
mechanisms	NULL
by	NULL
which	NULL
T	NULL
cell	NULL
lines	NULL
stimulated	NULL
with	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
and	NULL
phytohemagglutin	NULL
(	NULL
PHA	NULL
)	NULL
display	NULL
significantly	NULL
higher	NULL
levels	NULL
of	NULL
NF-BI	NULL
encoding	NULL
transcripts	NULL
than	NULL
cells	NULL
stimulated	NULL
with	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
,	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
both	NULL
stimuli	NULL
activate	NULL
NF-KB	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
kBI1	NULL
promoter	NULL
identified	NULL
an	NULL
Egr-1	NULL
site	NULL
which	NULL
was	NULL
found	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
both	NULL
the	NULL
PMA/	NULL
PH	NULL
A-mediated	NULL
induction	NULL
as	NULL
well	NULL
as	NULL
the	NULL
synergistic	NULL
activation	NULL
observed	NULL
after	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
RelA	NULL
subunit	NULL
of	NULL
NF-KB	NULL
and	NULL
Egr-1	NULL
.	NULL

Furthermore	NULL
,	NULL
Egr-1	NULL
induction	NULL
was	NULL
required	NULL
for	NULL
endogenous	NULL
NF-kBI	NULL
gene	NULL
expression	NULL
,	NULL
since	NULL
PMA/	NULL
PHA-stimulated	NULL
T	NULL
cell	NULL
lines	NULL
expressing	NULL
antisense	NULL
Egr-1	NULL
RNA	NULL
were	NULL
inhibited	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
upregulate	NULL
NF-B1	NULL
transcription	NULL
.	NULL

O	NULL
ur	NULL
studies	NULL
indicate	NULL
that	NULL
transcriptional	NULL
synergy	NULL
mediated	NULL
by	NULL
activation	NULL
of	NULL
both	NULL
Egr-1	NULL
and	NULL
NF-kB	NULL
may	NULL
have	NULL
important	NULL
ramifications	NULL
in	NULL
T	NULL
cell	NULL
development	NULL
by	NULL
upregulating	NULL
NF-BI	NULL
gene	NULL
expression	NULL
.	NULL

cell	NULL
activation	NULL
results	NULL
in	NULL
a	NULL
rapid	NULL
activation	NULL
of	NULL
NF-KB	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
which	NULL
appears	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
T	NULL
cell	NULL
proliferation	NULL
,	NULL
partly	NULL
because	NULL
of	NULL
the	NULL
involvement	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
upregulation	NULL
of	NULL
the	NULL
IL-2	NULL
and	NULL
cognate	NULL
receptor	NULL
(	NULL
IL-2R	NULL
)	NULL
genes	NULL
(	NULL
3	NULL
)	NULL
.	NULL

NF-KB	NULL
was	NULL
originally	NULL
described	NULL
to	NULL
be	NULL
composed	NULL
of	NULL
heterodimeric	NULL
subunits	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
proteins	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
and	NULL
is	NULL
typically	NULL
found	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
cells	NULL
as	NULL
an	NULL
inactive	NULL
precursor	NULL
complex	NULL
with	NULL
an	NULL
inhibitor	NULL
protein	NULL
,	NULL
IB	NULL
(	NULL
4	NULL
)	NULL
.	NULL

The	NULL
NF-kBI	NULL
gene	NULL
product	NULL
p105	NULL
is	NULL
processed	NULL
into	NULL
the	NULL
DNA-binding	NULL
subunit	NULL
of	NULL
p50	NULL
through	NULL
a	NULL
mechanism	NULL
that	NULL
requires	NULL
serine	NULL
phosphorylation	NULL
(	NULL
5	NULL
)	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
an	NULL
ATP-dependent	NULL
ubiquitin-proteasome	NULL
pathway	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

Cellular	NULL
activation	NULL
leads	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
transcripts	NULL
,	NULL
p105	NULL
processing	NULL
,	NULL
and	NULL
subsequent	NULL
p50	NULL
accumulation	NULL
in	NULL
both	NULL
fibroblasts	NULL
and	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
5	NULL
,	NULL
8	NULL
)	NULL
.	NULL

Although	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
regulation	NULL
of	NULL
NF-kBI	NULL
in	NULL
T	NULL
lymphocytes	NULL
,	NULL
its	NULL
expression	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
proliferation	NULL
after	NULL
costimulation	NULL
through	NULL
CD2	NULL
or	NULL
CD28	NULL
receptors	NULL
(	NULL
9	NULL
)	NULL
.	NULL

R	NULL
ecently	NULL
,	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
lymphocytes	NULL
derived	NULL
from	NULL
p50	NULL
cient	NULL
mice	NULL
display	NULL
defects	NULL
in	NULL
immune	NULL
responses	NULL
(	NULL
10	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
Sha	NULL
et	NULL
al	NULL
.	NULL

(	NULL
10	NULL
)	NULL
noted	NULL
that	NULL
T	NULL
cells	NULL
derived	NULL
from	NULL
these	NULL
animals	NULL
were	NULL
unable	NULL
to	NULL
effectively	NULL
proliferate	NULL
in	NULL
response	NULL
to	NULL
TCR	NULL
and	NULL
CD28	NULL
costimulation	NULL
.	NULL

Although	NULL
disruption	NULL
of	NULL
the	NULL
NF-kBI	NULL
gene	NULL
did	NULL
not	NULL
result	NULL
in	NULL
lethality	NULL
,	NULL
possibly	NULL
because	NULL
P.C	NULL
.	NULL

Cogswell	NULL
and	NULL
M.W	NULL
.	NULL

Mayo	NULL
contributed	NULL
equally	NULL
to	NULL
the	NULL
scientific	NULL
merit	NULL
and	NULL
preparation	NULL
of	NULL
this	NULL
manuscript	NULL
.	NULL

p52	NULL
could	NULL
substitute	NULL
for	NULL
p50	NULL
,	NULL
these	NULL
studies	NULL
strongly	NULL
suggest	NULL
that	NULL
the	NULL
p50	NULL
DNA-binding	NULL
component	NULL
of	NULL
NF-KB	NULL
is	NULL
critical	NULL
for	NULL
T	NULL
cell	NULL
proliferation	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
promoter	NULL
revealed	NULL
several	NULL
NF-KB	NULL
DNA-binding	NULL
sites	NULL
within	NULL
the	NULL
upstream	NULL
regulatory	NULL
region	NULL
which	NULL
are	NULL
capable	NULL
of	NULL
binding	NULL
p50	NULL
homodimers	NULL
,	NULL
p50/	NULL
p65	NULL
,	NULL
or	NULL
p50/c-Rel	NULL
heterodimers	NULL
and	NULL
,	NULL
in	NULL
part	NULL
,	NULL
account	NULL
for	NULL
the	NULL
ability	NULL
of	NULL
NF-KB	NULL
to	NULL
regulate	NULL
gene	NULL
expression	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
NF-	NULL
«	NULL
kBI	NULL
promoter	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
require	NULL
NF-KB	NULL
for	NULL
activity	NULL
,	NULL
it	NULL
is	NULL
presently	NULL
unclear	NULL
whether	NULL
NF-KB	NULL
needs	NULL
other	NULL
transcription	NULL
factors	NULL
to	NULL
mediate	NULL
a	NULL
transcriptional	NULL
response	NULL
.	NULL

This	NULL
is	NULL
especially	NULL
important	NULL
because	NULL
on	NULL
many	NULL
responsive	NULL
promoters	NULL
NF-kB	NULL
alone	NULL
is	NULL
insufficient	NULL
at	NULL
activating	NULL
transcription	NULL
(	NULL
2	NULL
)	NULL
.	NULL

T	NULL
cell	NULL
stimulation	NULL
mediated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
either	NULL
PMA	NULL
and	NULL
PHA	NULL
or	NULL
TNF-a	NULL
results	NULL
in	NULL
an	NULL
increase	NULL
in	NULL
NF-KBI	NULL
expression	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Both	NULL
stimuli	NULL
activate	NULL
NF-KB	NULL
nuclear	NULL
translocation	NULL
and	NULL
DNA-binding	NULL
within	NULL
15	NULL
to	NULL
30	NULL
min	NULL
(	NULL
14	NULL
)	NULL
;	NULL
however	NULL
,	NULL
phorbol	NULL
esters	NULL
in	NULL
combination	NULL
with	NULL
mitogens	NULL
result	NULL
in	NULL
a	NULL
greater	NULL
accumulation	NULL
of	NULL
NF-kB	NULL
]	NULL
transcripts	NULL
(	NULL
11	NULL
,	NULL
13	NULL
)	NULL
.	NULL

Our	NULL
research	NULL
demonstrates	NULL
that	NULL
full	NULL
PMA/	NULL
PHA-mediated	NULL
activation	NULL
of	NULL
the	NULL
NF-kBI	NULL
promoter	NULL
not	NULL
only	NULL
required	NULL
the	NULL
NF-KB	NULL
transcription	NULL
factor	NULL
,	NULL
but	NULL
also	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
early	NULL
growth	NULL
response	NULL
gene	NULL
product	NULL
(	NULL
Egr-1	NULL
)	NULL
'	NULL
.	NULL

Egr-1	NULL
,	NULL
also	NULL
known	NULL
as	NULL
NGFI-	NULL
A	NULL
,	NULL
Zif268	NULL
,	NULL
Krox-	NULL
24	NULL
,	NULL
and	NULL
Tis	NULL
8	NULL
,	NULL
is	NULL
transiently	NULL
induced	NULL
during	NULL
the	NULL
activation	NULL
of	NULL
T	NULL
'	NULL
A	NULL
bbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
Egr-1	NULL
;	NULL
early	NULL
growth	NULL
response	NULL
gene	NULL
prod-uct	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

491	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

©	NULL
The	NULL
R	NULL
ockefeller	NULL
University	NULL
Press	NULL
«	NULL
0022-1007/97/02/	NULL
491/07	NULL
$	NULL
2.00	NULL
Volume	NULL
185	NULL
,	NULL
Number	NULL
3	NULL
,	NULL
February	NULL
3	NULL
,	NULL
1997	NULL
491-497	NULL
cells	NULL
from	NULL
the	NULL
G	NULL
,	NULL
to	NULL
G	NULL
,	NULL
phase	NULL
in	NULL
response	NULL
to	NULL
various	NULL
cellular	NULL
stimuli	NULL
(	NULL
15	NULL
)	NULL
,	NULL
has	NULL
been	NULL
recently	NULL
demonstrated	NULL
to	NULL
be	NULL
required	NULL
for	NULL
T	NULL
cell	NULL
proliferation	NULL
,	NULL
and	NULL
is	NULL
known	NULL
to	NULL
regulate	NULL
transcription	NULL
of	NULL
several	NULL
genes	NULL
(	NULL
15-17	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
establishes	NULL
Egr-1	NULL
and	NULL
RelA	NULL
as	NULL
important	NULL
transcription	NULL
factors	NULL
capable	NULL
of	NULL
synergistically	NULL
transactivating	NULL
the	NULL
NF-KBI	NULL
promoter	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
Culture	NULL
and	NULL
T	NULL
ransient	NULL
T	NULL
rinsfection	NULL
Analysis	NULL
.	NULL

-	NULL
CEM	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
and	NULL
antibi-otics	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
by	NULL
supplementing	NULL
their	NULL
growth	NULL
medium	NULL
with	NULL
either	NULL
PMA	NULL
and	NULL
PHA	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
50	NULL
ng/ml	NULL
and	NULL
5	NULL
jwg/	NULL
ml	NULL
,	NULL
respec-tively	NULL
,	NULL
or	NULL
TNF-a	NULL
(	NULL
10	NULL
ng/	NULL
ml	NULL
;	NULL
Promega	NULL
Corp.	NULL
,	NULL
Madison	NULL
,	NULL
WJ	NULL
)	NULL
.	NULL

Transient	NULL
transfections	NULL
by	NULL
electroporation	NULL
(	NULL
11	NULL
)	NULL
and	NULL
luciferase	NULL
or	NULL
chloram-phenicol	NULL
acetyl-transferase	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
11	NULL
,	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

Plasmid	NULL
Construds	NULL
and	NULL
Site-dired¢ed	NULL
Mutagenesis	NULL
.	NULL

Both	NULL
the	NULL
NF-B1	NULL
promoter	NULL
constructs	NULL
,	NULL
p50HS-	NULL
and	NULL
p50SS-CAT	NULL
,	NULL
were	NULL
previously	NULL
described	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
SpS-	NULL
,	NULL
HiS-	NULL
,	NULL
and	NULL
AS-CAT	NULL
constructs	NULL
were	NULL
generated	NULL
by	NULL
digesting	NULL
the	NULL
p50HS-CAT	NULL
reporter	NULL
with	NULL
HindIII	NULL
,	NULL
and	NULL
SphI	NULL
,	NULL
Hinfl	NULL
,	NULL
or	NULL
Apol	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
SSLUC	NULL
reporter	NULL
plasmid	NULL
was	NULL
generated	NULL
by	NULL
cloning	NULL
the	NULL
Stul/	NULL
Smal	NULL
fragment	NULL
from	NULL
p50HS-CAT	NULL
into	NULL
the	NULL
pGL2	NULL
basic	NULL
reporter	NULL
containing	NULL
the	NULL
luciferase	NULL
gene	NULL
(	NULL
Promega	NULL
Corp.	NULL
)	NULL
.	NULL

The	NULL
Stul/	NULL
Smal	NULL
fragment	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
BI	NULL
promoter	NULL
was	NULL
subjected	NULL
to	NULL
site-directed	NULL
mutagenesis	NULL
using	NULL
a	NULL
two-staged	NULL
PCR	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
mNLUC	NULL
construct	NULL
,	NULL
containing	NULL
the	NULL
disrupted	NULL
289-bp	NULL
NF-kB	NULL
site	NULL
,	NULL
was	NULL
made	NULL
using	NULL
a	NULL
5	NULL
'	NULL
primer	NULL
(	NULL
5-ATGTAACTGAGACAC-GCTTAAATGGAATA-3	NULL
'	NULL
)	NULL
and	NULL
a	NULL
3	NULL
'	NULL
primer	NULL
(	NULL
5-AGGCCAT-CAGCGCCGCGCCATGGCCGCA-3	NULL
``	NULL
)	NULL
in	NULL
the	NULL
first	NULL
round	NULL
of	NULL
amplification	NULL
and	NULL
two	NULL
internal	NULL
primers	NULL
(	NULL
5-AGGCGCTTCCT-GGAAGCTTGAATACCGGCTCCAG-3	NULL
'	NULL
and	NULL
5-CTGGAG-CCGGTATTCAAGCTTCCAGGAAGCGCCT-3	NULL
'	NULL
)	NULL
which	NULL
mutated	NULL
the	NULL
kB	NULL
element	NULL
to	NULL
a	NULL
HindIII	NULL
site	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
kBI	NULL
promoter	NULL
sequences	NULL
containing	NULL
a	NULL
site-directed	NULL
mutation	NULL
within	NULL
the	NULL
Egr-1	NULL
DNA	NULL
binding	NULL
site	NULL
(	NULL
mELUC	NULL
)	NULL
was	NULL
created	NULL
using	NULL
the	NULL
same	NULL
5	NULL
'	NULL
and	NULL
3	NULL
``	NULL
primers	NULL
described	NULL
above	NULL
plus	NULL
two	NULL
internal	NULL
primers	NULL
GCAGCGAATTCGGGAGGTAGGGTC-3	NULL
'	NULL
)	NULL
and	NULL
(	NULL
5-GACCCT-ACCTCCCGAATTCGCTGCGTGCGC-3	NULL
'	NULL
)	NULL
which	NULL
destroyed	NULL
both	NULL
the	NULL
SP1/Egr-1	NULL
motif	NULL
and	NULL
created	NULL
a	NULL
unique	NULL
EcoRI	NULL
site	NULL
.	NULL

The	NULL
mNELUC	NULL
construct	NULL
was	NULL
created	NULL
by	NULL
mixing	NULL
the	NULL
mutant	NULL
Egr-1	NULL
oligos	NULL
described	NULL
above	NULL
and	NULL
using	NULL
the	NULL
mNF-B	NULL
fragment	NULL
as	NULL
a	NULL
tem-plate	NULL
.	NULL

The	NULL
PCR	NULL
amplified	NULL
promoter	NULL
fragments	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
SSLUC	NULL
construct	NULL
by	NULL
replacing	NULL
the	NULL
wild-type	NULL
Pvull/	NULL
Smal	NULL
fragment	NULL
with	NULL
the	NULL
corresponding	NULL
site-directed	NULL
mutant	NULL
promoter	NULL
sequences	NULL
.	NULL

Nucleotide	NULL
sequences	NULL
of	NULL
mN	NULL
,	NULL
mE	NULL
,	NULL
and	NULL
mNELUC	NULL
constructs	NULL
were	NULL
confirmed	NULL
by	NULL
sequence	NULL
analysis	NULL
.	NULL

Northem	NULL
Blot	NULL
and	NULL
Elearophoresis	NULL
Mobility	NULL
Shift	NULL
Analysis	NULL
.	NULL

-	NULL
Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
CEM	NULL
cells	NULL
using	NULL
the	NULL
RNeasy	NULL
total	NULL
RNA	NULL
kit	NULL
(	NULL
Qiagen	NULL
,	NULL
Inc.	NULL
,	NULL
Chatsworth	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
isolated	NULL
and	NULL
electrophoresis	NULL
mobility	NULL
shift	NULL
analyses	NULL
(	NULL
EMSAs	NULL
)	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
11	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
BI	NULL
promoter	NULL
Egr-1	NULL
DNA	NULL
binding	NULL
site	NULL
(	NULL
5'-TCGACTCCCGCCCCCGCTGCG-3	NULL
'	NULL
and	NULL
5-TCGACGC-AGCGGGGGCGGGAG-3	NULL
'	NULL
)	NULL
were	NULL
radiolabeled	NULL
using	NULL
«	NULL
-	NULL
[	NULL
P	NULL
]	NULL
dCTP	NULL
and	NULL
the	NULL
Klenow	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
I	NULL
.	NULL

For	NULL
antibody	NULL
super	NULL
shift	NULL
assays	NULL
and	NULL
competition	NULL
experiments	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
preincubated	NULL
(	NULL
10	NULL
min	NULL
,	NULL
room	NULL
temperature	NULL
)	NULL
with	NULL
either	NULL
1	NULL
ug	NULL
of	NULL
antiserum	NULL
or	NULL
with	NULL
a	NULL
nonradioactive	NULL
double	NULL
stranded	NULL
oligonucle-	NULL
otide	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
radiolabeled	NULL
gel	NULL
shift	NULL
probe	NULL
.	NULL

The	NULL
mutant	NULL
Egr-1	NULL
probe	NULL
(	NULL
annealed	NULL
5-TCGACTCCCGAATTCG-CTGCG-3	NULL
'	NULL
and	NULL
5-TCGACGCAGCGAATTCGGGAG-3	NULL
'	NULL
)	NULL
was	NULL
used	NULL
in	NULL
competition	NULL
assays	NULL
.	NULL

The	NULL
Egr-1-specific	NULL
antibody	NULL
(	NULL
SC	NULL
No	NULL
.	NULL

189	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Generation	NULL
of	NULL
Stable	NULL
Cell	NULL
Lines	NULL
.	NULL

The	NULL
full-length	NULL
human	NULL
Egr-1	NULL
cDNA	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
EcoR	NULL
1	NULL
site	NULL
of	NULL
the	NULL
CMV-5	NULL
expression	NULL
vector	NULL
in	NULL
the	NULL
antisense	NULL
orientation	NULL
.	NULL

CEM	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
either	NULL
CMV-AsEgr-	NULL
1	NULL
or	NULL
with	NULL
the	NULL
CMV-5	NULL
control	NULL
vector	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
peDNA-3.1	NULL
Neo	NULL
(	NULL
Invitrogen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Trans	NULL
fected	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
complete	NULL
RPMI-1640	NULL
medium	NULL
supplemented	NULL
with	NULL
1.5	NULL
mg/	NULL
ml	NULL
of	NULL
Geneticin	NULL
(	NULL
GIBCO	NULL
BRL	NULL
,	NULL
Gaithers	NULL
burg	NULL
,	NULL
MD	NULL
)	NULL
and	NULL
resistant	NULL
clones	NULL
were	NULL
isolated	NULL
.	NULL

R	NULL
Nase	NULL
protection	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
RPA	NULL
II	NULL
kit	NULL
(	NULL
Ambion	NULL
,	NULL
Inc.	NULL
,	NULL
Aus-tin	NULL
,	NULL
TX	NULL
)	NULL
to	NULL
ensure	NULL
that	NULL
the	NULL
CEM/	NULL
AsEgr-1	NULL
cells	NULL
were	NULL
expressing	NULL
the	NULL
CMV-driven	NULL
antisense	NULL
human	NULL
Ege	NULL
/	NULL
transcript	NULL
.	NULL

Results	NULL
and	NULL
Discussion	NULL
Differential	NULL
Expression	NULL
of	NULL
NF-kB	NULL
mRNA	NULL
After	NULL
PMA/	NULL
PHA-	NULL
or	NULL
TN	NULL
F-o-Stimulation	NULL
.	NULL

_	NULL
To	NULL
determine	NULL
whether	NULL
differential	NULL
expression	NULL
of	NULL
NF-kBI	NULL
mRNA	NULL
was	NULL
observed	NULL
after	NULL
stimulation	NULL
by	NULL
PMA	NULL
and	NULL
PHA	NULL
or	NULL
TNF-a	NULL
,	NULL
Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
on	NULL
total	NULL
cellular	NULL
RN	NULL
A	NULL
isolated	NULL
from	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
CEM	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
,	NULL
NF-BI	NULL
mRNA	NULL
began	NULL
to	NULL
accumulate	NULL
within	NULL
1	NULL
h	NULL
of	NULL
stimulation	NULL
with	NULL
PMA	NULL
and	NULL
PHA	NULL
,	NULL
and	NULL
by	NULL
4	NULL
h	NULL
a	NULL
significant	NULL
induction	NULL
(	NULL
10-fold	NULL
)	NULL
was	NULL
observed	NULL
in	NULL
CEM	NULL
cells	NULL
Although	NULL
TNF-a-stim-ulated	NULL
cells	NULL
also	NULL
displayed	NULL
increases	NULL
in	NULL
NF-KkBI	NULL
transcripts	NULL
with	NULL
similar	NULL
kinetics	NULL
,	NULL
a	NULL
substantially	NULL
lower	NULL
accumulation	NULL
of	NULL
mR	NULL
NA	NULL
was	NULL
observed	NULL
over	NULL
the	NULL
4-h	NULL
time	NULL
course	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
kBI	NULL
Promoter	NULL
Region	NULL
Required	NULL
for	NULL
PMA/	NULL
PHA	NULL
-R	NULL
esponsive	NULL
Upregulation	NULL
.	NULL

-	NULL
To	NULL
determine	NULL
whether	NULL
the	NULL
increase	NULL
in	NULL
NF-kBI	NULL
mRNA	NULL
,	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
,	NULL
was	NULL
due	NULL
to	NULL
transcriptional	NULL
upregulation	NULL
of	NULL
the	NULL
promoter	NULL
and	NULL
not	NULL
due	NULL
to	NULL
PMA/PHA-induced	NULL
message	NULL
stabilization	NULL
,	NULL
CEM	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
p50HS-CAT	NULL
NF-kBI	NULL
promoter	NULL
construct	NULL
and	NULL
stimulated	NULL
with	NULL
either	NULL
PMA/	NULL
PHA	NULL
or	NULL
TNF-a	NULL
for	NULL
24	NULL
h.	NULL
As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
,	NULL
the	NULL
NF-kB	NULL
!	NULL

promoter	NULL
(	NULL
p50HS-CAT	NULL
)	NULL
was	NULL
strongly	NULL
activated	NULL
in	NULL
CEM	NULL
cells	NULL
after	NULL
PMA/PHA	NULL
stimulation	NULL
,	NULL
but	NULL
only	NULL
weakly	NULL
after	NULL
TNF-a	NULL
addition	NULL
,	NULL
suggesting	NULL
that	NULL
PMA/	NULL
PH	NULL
A-mediated	NULL
activation	NULL
of	NULL
the	NULL
NF-kBI	NULL
promoter	NULL
was	NULL
through	NULL
a	NULL
transcrip-tion-dependent	NULL
mechanism	NULL
.	NULL

To	NULL
localize	NULL
the	NULL
PMA/	NULL
PH	NULL
A-responsive	NULL
region	NULL
within	NULL
the	NULL
NF-	NULL
«	NULL
kBI1	NULL
promoter	NULL
,	NULL
a	NULL
series	NULL
of	NULL
deletion	NULL
promoter	NULL
constructs	NULL
were	NULL
made	NULL
.	NULL

CEM	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
each	NULL
reporter	NULL
construct	NULL
and	NULL
then	NULL
either	NULL
stimulated	NULL
with	NULL
PMA/	NULL
PHA	NULL
or	NULL
with	NULL
TNF-a	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
,	NULL
no	NULL
significant	NULL
difference	NULL
in	NULL
stimulation	NULL
was	NULL
observed	NULL
between	NULL
the	NULL
HS-	NULL
,	NULL
the	NULL
SS-	NULL
,	NULL
or	NULL
the	NULL
SpS-CAT	NULL
constructs	NULL
.	NULL

However	NULL
,	NULL
the	NULL
HiS-CAT	NULL
reporter	NULL
,	NULL
which	NULL
lacked	NULL
the	NULL
-289	NULL
NF-KB	NULL
site	NULL
,	NULL
displayed	NULL
a	NULL
significant	NULL
decrease	NULL
in	NULL
promoter	NULL
activity	NULL
after	NULL
stimulation	NULL
by	NULL
either	NULL
PMA/PHA	NULL
or	NULL
TNF-	NULL
«	NULL
.	NULL

The	NULL
AS-C	NULL
AT	NULL
reporter	NULL
,	NULL
lacking	NULL
both	NULL
the	NULL
-103	NULL
and	NULL
-11	NULL
kB	NULL
sites	NULL
,	NULL
was	NULL
greatly	NULL
diminished	NULL
in	NULL
response	NULL
to	NULL
PMA/PHA-	NULL
and	NULL
TNF-o-mediated	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
)	NULL
.	NULL

Collectively	NULL
,	NULL
this	NULL
data	NULL
indicates	NULL
that	NULL
the	NULL
region	NULL
between	NULL
the	NULL
SphI	NULL
site	NULL
(	NULL
-425	NULL
)	NULL
492	NULL
_	NULL
Egr-1	NULL
and	NULL
NF-KB	NULL
Control	NULL
T	NULL
Cell-activated	NULL
NF-BI	NULL
Transcription	NULL
A	NULL
.	NULL

Figure	NULL
1	NULL
.	NULL

NF-	NULL
«	NULL
kBI	NULL
gene	NULL
expression	NULL
and	NULL
+_PMA/PHA	NULL
(	NULL
h	NULL
)	NULL
+	NULL
TNF-a	NULL
(	NULL
h	NULL
)	NULL
promoter	NULL
analysis	NULL
in	NULL
CEM	NULL
cells	NULL
after	NULL
PMA/	NULL
6	NULL
|	NULL
£0	NULL
j	NULL
§	NULL
4	NULL
II	NULL
g	NULL
q	NULL
|	NULL
PHA	NULL
or	NULL
TNF-a	NULL
stimulation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
RNAs	NULL
h	NULL
*	NULL
2	NULL
4	NULL
were	NULL
isolated	NULL
from	NULL
CEM	NULL
cells	NULL
after	NULL
addition	NULL
a	NULL
nun-n	NULL
“	NULL
oe	NULL
sward	NULL
que	NULL
4000	NULL
-t-	NULL
of	NULL
either	NULL
PMA/	NULL
PHA	NULL
(	NULL
50	NULL
ng	NULL
and	NULL
5	NULL
g/	NULL
ml	NULL
)	NULL
or	NULL
TNF-	NULL
«	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
over	NULL
the	NULL
time	NULL
course	NULL
Fold	NULL
indicated	NULL
.	NULL

RNAs	NULL
were	NULL
detected	NULL
using	NULL
a	NULL
°P-Accumulation	NULL
0	NULL
12	NULL
23	NULL
93	NULL
102	NULL
1.3	NULL
17	NULL
28	NULL
31	NULL
labeled	NULL
NF-KB	NULL
!	NULL

-specific	NULL
probe	NULL
.	NULL

Transcripts	NULL
encoding	NULL
were	NULL
quantitated	NULL
by	NULL
den-sitometric	NULL
scanning	NULL
of	NULL
autoradiograms	NULL
and	NULL
B	NULL
NF-	NULL
«	NULL
xB1	NULL
Promoter	NULL
the	NULL
fold	NULL
accumulation	NULL
of	NULL
mRNAs	NULL
were	NULL
cal-e	NULL
NF	NULL
<	NULL
8	NULL
culated	NULL
after	NULL
normalization	NULL
to	NULL
B-actin	NULL
.	NULL

(	NULL
B	NULL
)	NULL
$	NULL
&	NULL
A	NULL
A	NULL
Q°\	NULL
o	NULL
Egr-1	NULL
g	NULL
Schematic	NULL
of	NULL
the	NULL
NF-KBI	NULL
promoter	NULL
depict	NULL
--	NULL
&	NULL
Ey	NULL
&	NULL
CS	NULL
=	NULL
&	NULL
ing	NULL
the	NULL
Egr-1	NULL
and	NULL
NF-kB	NULL
binding	NULL
sites	NULL
.	NULL

|	NULL
}	NULL
M	NULL
o	NULL
}	NULL
o-	NULL
7	NULL
CAT	NULL
CEM	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
either	NULL
the	NULL
890	NULL
-642	NULL
-455	NULL
-258	NULL
-9	NULL
*	NULL
+354	NULL
HS-CAT	NULL
reporter	NULL
or	NULL
with	NULL
various	NULL
deletion	NULL
Construct	NULL
Fold	NULL
Induction	NULL
constructs	NULL
(	NULL
SS-	NULL
,	NULL
SpS-	NULL
,	NULL
HiS-	NULL
,	NULL
and	NULL
AS-CAT	NULL
)	NULL
.	NULL

+	NULL
PMA/PHA	NULL
+TNFq	NULL
18	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
HS	NULL
-890/+354	NULL
11.1	NULL
£1.2	NULL
3.6	NULL
£	NULL
.8	NULL
with	NULL
either	NULL
PMA/PHA	NULL
(	NULL
50	NULL
ng	NULL
and	NULL
5	NULL
g/	NULL
ss	NULL
-642/+354	NULL
10.4	NULL
£	NULL
1.6	NULL
3.4	NULL
%	NULL
.4	NULL
m1	NULL
)	NULL
or	NULL
TNF-	NULL
«	NULL
(	NULL
10	NULL
ng/	NULL
ml	NULL
)	NULL
and	NULL
CAT	NULL
activity	NULL
SpS	NULL
-425/4354	NULL
18.2	NULL
£1.8	NULL
8.8	NULL
+	NULL
.6	NULL
was	NULL
analyzed	NULL
.	NULL

Transfection	NULL
experiments	NULL
His	NULL
-258/+354	NULL
5.94	NULL
.9	NULL
a	NULL
2	NULL
:	NULL
2	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
and	NULL
the	NULL
mean	NULL
AS	NULL
-9/+354	NULL
1.3	NULL
;	NULL
.8	NULL
1:2	NULL
;	NULL
Z4	NULL
fold	NULL
tinduction	NULL
and	NULL
the	NULL
standard	NULL
deviations	NULL
are	NULL
shown	NULL
.	NULL

A	NULL
and	NULL
the	NULL
Apol	NULL
site	NULL
(	NULL
-9	NULL
)	NULL
was	NULL
critical	NULL
for	NULL
both	NULL
inducers	NULL
,	NULL
but	NULL
4	NULL
a	NULL
3	NULL
40	NULL
5006	NULL
that	NULL
PMA/PHA	NULL
stimulation	NULL
resulted	NULL
in	NULL
a	NULL
higher	NULL
fold	NULL
activation	NULL
than	NULL
TNF-a	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
deletion	NULL
analysis	NULL
of	NULL
the	NULL
sg	NULL
{	NULL
NF-kBI1	NULL
promoter	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
both	NULL
stimuli	NULL
may	NULL
use	NULL
NF-KB	NULL
,	NULL
but	NULL
that	NULL
the	NULL
PMA/PHA	NULL
stimulation	NULL
must	NULL
acti-	NULL
B	NULL
+	NULL
PMA/PHA	NULL
(	NULL
h	NULL
)	NULL
+	NULL
TNF-a	NULL
(	NULL
h	NULL
)	NULL
F	NULL
J	NULL
1	NULL
0	NULL
.25	NULL
.5	NULL
1	NULL
20	NULL
4	NULL
.25	NULL
250	NULL
1	NULL
2	NULL
4	NULL
Egr-1	NULL
m	NULL
n	NULL
.	NULL

.	NULL

NS	NULL
{	NULL
Figure	NULL
2	NULL
.	NULL

-	NULL
Identification	NULL
of	NULL
an	NULL
Egr-1	NULL
DNA	NULL
binding	NULL
site	NULL
within	NULL
the	NULL
NF	NULL
B1	NULL
promoter	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nuclear	NULL
extracts	NULL
were	NULL
isolated	NULL
from	NULL
CEM	NULL
cells	NULL
after	NULL
a	NULL
2	NULL
h	NULL
PMA/	NULL
PHA	NULL
stimulation	NULL
in	NULL
either	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
cycloheximide	NULL
(	NULL
50	NULL
pg/	NULL
ml	NULL
,	NULL
30	NULL
min	NULL
pretreatment	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
5	NULL
pg	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
P-labeled	NULL
probe	NULL
corresponding	NULL
to	NULL
the	NULL
68-bp	NULL
Egr-1	NULL
site	NULL
.	NULL

Competition	NULL
assays	NULL
and	NULL
antibody	NULL
supershift	NULL
experiments	NULL
were	NULL
performed	NULL
by	NULL
preincubating	NULL
nuclear	NULL
extracts	NULL
(	NULL
15	NULL
min	NULL
)	NULL
with	NULL
either	NULL
unlabeled	NULL
mutant	NULL
Egr-1	NULL
(	NULL
mEgr-1	NULL
)	NULL
or	NULL
wild-type	NULL
Egr-1	NULL
oligonucleotide	NULL
(	NULL
50	NULL
ng	NULL
total	NULL
)	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
probe	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
unstimulated	NULL
cells	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
PMA/	NULL
PHA	NULL
for	NULL
493	NULL
_	NULL
Cogswell	NULL
et	NULL
al	NULL
.	NULL

vate	NULL
additional	NULL
transcription	NULL
factors	NULL
not	NULL
induced	NULL
by	NULL
TNF-a	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
BI	NULL
Promoter	NULL
Contains	NULL
an	NULL
Egr-1	NULL
Consensus	NULL
Site	NULL
and	NULL
T	NULL
Cells	NULL
Stimulated	NULL
with	NULL
PMA	NULL
and	NULL
PHA	NULL
,	NULL
but	NULL
not	NULL
TNF-a	NULL
,	NULL
Display	NULL
Egr-1	NULL
DNA	NULL
Binding	NULL
_-	NULL
Computer	NULL
analysis	NULL
of	NULL
the	NULL
SphI/	NULL
Apo	NULL
fragment	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
kBI	NULL
promoter	NULL
identified	NULL
potential	NULL
DNA-binding	NULL
motifs	NULL
for	NULL
five	NULL
different	NULL
transcription	NULL
factors	NULL
including	NULL
AP-1	NULL
,	NULL
E2F	NULL
,	NULL
Egr-1	NULL
,	NULL
NF-KB	NULL
,	NULL
and	NULL
SP1	NULL
.	NULL

Of	NULL
these	NULL
,	NULL
NF-kB	NULL
,	NULL
Egr-1	NULL
,	NULL
and	NULL
AP-1	NULL
are	NULL
known	NULL
to	NULL
display	NULL
increased	NULL
transactivation	NULL
potential	NULL
after	NULL
PMA	NULL
stimulation	NULL
(	NULL
2	NULL
,	NULL
15	NULL
,	NULL
21	NULL
)	NULL
.	NULL

Since	NULL
PMA/	NULL
PHA	NULL
and	NULL
TNF-a	NULL
both	NULL
activated	NULL
NF-KB	NULL
,	NULL
we	NULL
excluded	NULL
this	NULL
transcription	NULL
factor	NULL
as	NULL
the	NULL
nuclear	NULL
factor	NULL
responsible	NULL
for	NULL
differentially	NULL
regulating	NULL
the	NULL
NF-kBI	NULL
promoter	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
putative	NULL
AP-1	NULL
site	NULL
located	NULL
in	NULL
the	NULL
NF-KkBI	NULL
promoter	NULL
was	NULL
not	NULL
found	NULL
to	NULL
affect	NULL
PMA-induced	NULL
transactivation	NULL
of	NULL
the	NULL
NF-BI	NULL
promoter	NULL
(	NULL
12	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
extracts	NULL
from	NULL
PMA/	NULL
PHA-stimulated	NULL
cells	NULL
would	NULL
display	NULL
Egr-	NULL
1	NULL
binding	NULL
,	NULL
EMSAs	NULL
were	NULL
performed	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
,	NULL
a	NULL
P	NULL
double	NULL
stranded	NULL
oligonucleotide	NULL
probe	NULL
corresponding	NULL
to	NULL
the	NULL
68-bp	NULL
Egr-1	NULL
site	NULL
within	NULL
the	NULL
NF-BI	NULL
promoter	NULL
bound	NULL
a	NULL
nuclear	NULL
protein	NULL
which	NULL
was	NULL
present	NULL
in	NULL
PMA/	NULL
PHA-stimulated	NULL
cell	NULL
extracts	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
but	NULL
not	NULL
in	NULL
unstimulated	NULL
cell	NULL
extracts	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

This	NULL
DNA-protein	NULL
complex	NULL
could	NULL
also	NULL
be	NULL
2	NULL
h	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
PMA/PHA	NULL
+	NULL
wild-type	NULL
Egr-1	NULL
oligo	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
PMA/	NULL
PHA	NULL
+	NULL
mEgr-1	NULL
oligo	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
PMA/PHA	NULL
+	NULL
Egr-1-specific	NULL
antibody	NULL
;	NULL
lane	NULL
6	NULL
,	NULL
pretreatment	NULL
with	NULL
cycloheximide	NULL
(	NULL
30	NULL
min	NULL
)	NULL
+	NULL
PMA/PHA	NULL
for	NULL
2	NULL
h.	NULL
SS	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
the	NULL
Egr-1	NULL
+	NULL
antibody	NULL
supershift	NULL
complex	NULL
;	NULL
NS	NULL
identifies	NULL
nonspecific	NULL
bands	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Nuclear	NULL
proteins	NULL
from	NULL
CEM	NULL
cells	NULL
were	NULL
isolated	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
either	NULL
PMA/	NULL
PHA	NULL
or	NULL
TNF-a	NULL
over	NULL
the	NULL
indicated	NULL
time	NULL
course	NULL
and	NULL
EMSAs	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
P-labeled	NULL
Egr-1	NULL
site	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
unbound	NULL
P-labeled	NULL
probe	NULL
is	NULL
not	NULL
shown	NULL
in	NULL
both	NULL
A	NULL
and	NULL
B	NULL
.	NULL

A	NULL
B	NULL
25	NULL
400	NULL
B	NULL
Unstimulated	NULL
204	NULL
EJ	NULL
PMA/PHA	NULL
300	NULL
B	NULL
TNF-	NULL
«	NULL
&	NULL
200	NULL
7	NULL
S	NULL
H3	NULL
5	NULL
E	NULL
E	NULL
@	NULL
1507	NULL
C	NULL
3	NULL
s	NULL
0	NULL
<	NULL
4	NULL
3	NULL
100+	NULL
o	NULL
lh	NULL
50	NULL
t	NULL
o-	NULL
$	NULL
y	NULL
mNLUC	NULL
200	NULL
-	NULL
B	NULL
vector	NULL
Control	NULL
IJ	NULL
vector	NULL
Sontrot	NULL
&	NULL
Egri	NULL
RelA	NULL
Beg	NULL
EZ	NULL
]	NULL
Rela	NULL
+	NULL
Egr	NULL
150	NULL
4	NULL
Z	NULL
o	NULL
'	NULL
_	NULL
<	NULL
2	NULL
100	NULL
5	NULL
<	NULL
[	NULL
a	NULL
)	NULL
4	NULL
O	NULL
L	NULL
50	NULL
7	NULL
C	NULL
PMA/PHA	NULL
-	NULL
0	NULL
40	NULL
o-	NULL
-	NULL
4+	NULL
mELUC	NULL
mNELUC	NULL
TNF-a	NULL
|	NULL
c	NULL
c	NULL
poe	NULL
-	NULL
o£	NULL
Figure	NULL
3	NULL
.	NULL

-	NULL
The	NULL
Egr-1	NULL
DNA	NULL
binding	NULL
site	NULL
is	NULL
required	NULL
for	NULL
PMA/	NULL
PH	NULL
A-responsive	NULL
activation	NULL
and	NULL
for	NULL
transcriptional	NULL
synergy	NULL
mediated	NULL
by	NULL
RelA	NULL
and	NULL
Egr-1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
CEM	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
either	NULL
the	NULL
wild-type	NULL
NF-	NULL
«	NULL
BI	NULL
promoter	NULL
(	NULL
SSLUC	NULL
)	NULL
or	NULL
with	NULL
each	NULL
of	NULL
the	NULL
site-directed	NULL
mutants	NULL
including	NULL
(	NULL
a	NULL
)	NULL
mNLUC	NULL
,	NULL
which	NULL
contained	NULL
a	NULL
mutated	NULL
NF-KB	NULL
site	NULL
at	NULL
position	NULL
-289	NULL
,	NULL
(	NULL
b	NULL
)	NULL
mELUC	NULL
,	NULL
which	NULL
contained	NULL
a	NULL
disrupted	NULL
68-bp	NULL
Egr-1	NULL
site	NULL
,	NULL
and	NULL
(	NULL
c	NULL
)	NULL
mNELUC	NULL
,	NULL
which	NULL
contained	NULL
mutated	NULL
NF-B	NULL
and	NULL
Egr-1	NULL
sites	NULL
,	NULL
and	NULL
18	NULL
h	NULL
later	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
PMA/PHA	NULL
or	NULL
TNF-	NULL
«	NULL
.	NULL

24	NULL
h	NULL
after	NULL
stimulation	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
harvested	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

(	NULL
B	NULL
)	NULL
CEM	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
either	NULL
the	NULL
SSLUC	NULL
construct	NULL
or	NULL
with	NULL
mutant	NULL
reporters	NULL
(	NULL
mN	NULL
,	NULL
ME	NULL
,	NULL
mNE	NULL
;	NULL
5	NULL
ug	NULL
each	NULL
)	NULL
and	NULL
with	NULL
various	NULL
expression	NULL
vectors	NULL
(	NULL
5	NULL
pg	NULL
)	NULL
including	NULL
an	NULL
empty	NULL
vector	NULL
control	NULL
,	NULL
RelA	NULL
,	NULL
Egr-1	NULL
,	NULL
or	NULL
RelA	NULL
plus	NULL
Egr-1	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
and	NULL
luciferase	NULL
activities	NULL
were	NULL
determined	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
SSLUC	NULL
construct	NULL
was	NULL
transfected	NULL
into	NULL
CEM	NULL
cells	NULL
along	NULL
with	NULL
either	NULL
the	NULL
vector	NULL
control	NULL
or	NULL
with	NULL
an	NULL
Egr-1	NULL
expression	NULL
construct	NULL
.	NULL

18	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
either	NULL
left	NULL
untreated	NULL
or	NULL
stimulated	NULL
with	NULL
PMA/PHA	NULL
or	NULL
TNF-	NULL
«	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
24	NULL
h	NULL
after	NULL
stimulation	NULL
and	NULL
extracts	NULL
were	NULL
analyzed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

All	NULL
transfection	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
in	NULL
three	NULL
inde-	NULL
pendent	NULL
experiments	NULL
.	NULL

competed	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
wild-type	NULL
unlabeled	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
equal	NULL
concentrations	NULL
of	NULL
a	NULL
corresponding	NULL
mutant	NULL
Egr-	NULL
1	NULL
site	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
this	NULL
complex	NULL
contained	NULL
Egr-1	NULL
protein	NULL
since	NULL
incubation	NULL
with	NULL
an	NULL
Egr-1-specific	NULL
antibody	NULL
completely	NULL
supershifted	NULL
the	NULL
nuclear	NULL
protein	NULL
bound	NULL
to	NULL
the	NULL
*P-probe	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Pretreatment	NULL
with	NULL
cyclo-heximide	NULL
,	NULL
which	NULL
has	NULL
been	NULL
previously	NULL
demonstrated	NULL
to	NULL
block	NULL
PMA-mediated	NULL
increases	NULL
in	NULL
Egr-1	NULL
protein	NULL
(	NULL
15	NULL
)	NULL
,	NULL
prevented	NULL
the	NULL
detection	NULL
of	NULL
Egr-	NULL
1-specific	NULL
binding	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Although	NULL
we	NULL
do	NULL
not	NULL
effectively	NULL
detect	NULL
SP1	NULL
binding	NULL
under	NULL
our	NULL
EMSA	NULL
conditions	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
,	NULL
we	NULL
observed	NULL
constitutive	NULL
SP1	NULL
binding	NULL
in	NULL
nuclear	NULL
extracts	NULL
isolated	NULL
from	NULL
CEM	NULL
cells	NULL
using	NULL
a	NULL
modified	NULL
binding	NULL
protocol	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Since	NULL
SPI	NULL
binding	NULL
to	NULL
the	NULL
-68	NULL
site	NULL
was	NULL
constitutive	NULL
and	NULL
completely	NULL
independent	NULL
of	NULL
cellular	NULL
stimulation	NULL
mediated	NULL
by	NULL
either	NULL
PMA/	NULL
PHA	NULL
or	NULL
TNF-a	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
we	NULL
chose	NULL
to	NULL
focus	NULL
on	NULL
the	NULL
inducible	NULL
binding	NULL
of	NULL
the	NULL
Egr-1	NULL
transcription	NULL
factor	NULL
.	NULL

To	NULL
elucidate	NULL
whether	NULL
differential	NULL
Egr-1	NULL
binding	NULL
was	NULL
observed	NULL
in	NULL
T	NULL
cells	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
either	NULL
PMA/PHA	NULL
or	NULL
TNF-a	NULL
,	NULL
nuclear	NULL
proteins	NULL
were	NULL
isolated	NULL
from	NULL
stimulated	NULL
CEM	NULL
cells	NULL
over	NULL
a	NULL
4	NULL
h	NULL
time	NULL
course	NULL
and	NULL
EMSAs	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
Egr-1	NULL
consensus	NULL
site	NULL
.	NULL

After	NULL
stimulation	NULL
with	NULL
PMA/PHA	NULL
,	NULL
Egr-1	NULL
binding	NULL
begins	NULL
to	NULL
appear	NULL
within	NULL
30	NULL
min	NULL
and	NULL
continues	NULL
to	NULL
increase	NULL
at	NULL
both	NULL
1	NULL
and	NULL
2	NULL
h	NULL
with	NULL
a	NULL
slight	NULL
decrease	NULL
seen	NULL
at	NULL
4	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
no	NULL
Egr-1	NULL
binding	NULL
was	NULL
observed	NULL
in	NULL
CEM	NULL
cell	NULL
extracts	NULL
after	NULL
TNF-	NULL
«	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
both	NULL
PMA/	NULL
PHA-	NULL
and	NULL
TNF-	NULL
«	NULL
-stimulated	NULL
CEM	NULL
cells	NULL
demonstrated	NULL
NF-rB-specific	NULL
binding	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
each	NULL
inducer	NULL
,	NULL
confirming	NULL
that	NULL
CEM	NULL
cells	NULL
were	NULL
capable	NULL
of	NULL
responding	NULL
to	NULL
TNF-a	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Identical	NULL
results	NULL
to	NULL
those	NULL
obtained	NULL
in	NULL
the	NULL
CEM	NULL
cell	NULL
line	NULL
were	NULL
demonstrated	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
-68	NULL
site	NULL
located	NULL
in	NULL
the	NULL
NF-BI	NULL
promoter	NULL
is	NULL
capable	NULL
of	NULL
binding	NULL
the	NULL
Egr-1	NULL
transcription	NULL
factor	NULL
and	NULL
that	NULL
,	NULL
unlike	NULL
PMA/PHA	NULL
stimulation	NULL
,	NULL
TNF-	NULL
«	NULL
fails	NULL
to	NULL
stimulate	NULL
Egr-	NULL
1	NULL
binding	NULL
in	NULL
T	NULL
cell	NULL
lines	NULL
.	NULL

Effiaent	NULL
PMA/PHA-Responsive	NULL
Adivation	NULL
of	NULL
the	NULL
NF-kBI	NULL
Promoter	NULL
Requires	NULL
the	NULL
Egr-1	NULL
DNA	NULL
Binding	NULL
Site	NULL
_	NULL
To	NULL
determine	NULL
whether	NULL
Egr-1	NULL
is	NULL
required	NULL
for	NULL
PMA/	NULL
PHA	NULL
responsive	NULL
activation	NULL
of	NULL
the	NULL
NF-kBI	NULL
promoter	NULL
,	NULL
site-directed	NULL
mutagenesis	NULL
was	NULL
performed	NULL
.	NULL

Since	NULL
the	NULL
NF-kBI	NULL
promoter	NULL
is	NULL
regulated	NULL
directly	NULL
by	NULL
NF-KB	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
,	NULL
we	NULL
chose	NULL
to	NULL
mutate	NULL
the	NULL
-289	NULL
kB	NULL
motif	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
the	NULL
-68	NULL
Egr-1	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
four	NULL
luciferase	NULL
NF-kBI	NULL
promoter	NULL
constructs	NULL
included	NULL
(	NULL
@	NULL
)	NULL
SSLUC	NULL
,	NULL
the	NULL
wild-type	NULL
construct	NULL
,	NULL
(	NULL
5	NULL
)	NULL
mNLUC	NULL
,	NULL
which	NULL
contained	NULL
a	NULL
mutated	NULL
NF-KB	NULL
site	NULL
at	NULL
position	NULL
-289	NULL
,	NULL
(	NULL
0	NULL
)	NULL
mELUC	NULL
,	NULL
which	NULL
contained	NULL
the	NULL
disrupted	NULL
68-bp	NULL
Egr-1	NULL
site	NULL
,	NULL
and	NULL
(	NULL
d	NULL
)	NULL
mNELUC	NULL
,	NULL
which	NULL
contained	NULL
mutated	NULL
NF-KB	NULL
and	NULL
Egr-1	NULL
sites	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
,	NULL
site-directed	NULL
mutagenesis	NULL
of	NULL
the	NULL
Egr-1	NULL
binding	NULL
element	NULL
(	NULL
mELUC	NULL
)	NULL
significantly	NULL
diminished	NULL
PMA/PHA-responsive	NULL
activation	NULL
of	NULL
the	NULL
NF-kBI	NULL
promoter	NULL
,	NULL
but	NULL
had	NULL
very	NULL
little	NULL
or	NULL
no	NULL
effect	NULL
on	NULL
TNF-o-mediated	NULL
stimulation	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutating	NULL
the	NULL
NF-kB	NULL
-289	NULL
site	NULL
alone	NULL
had	NULL
very	NULL
little	NULL
effect	NULL
on	NULL
either	NULL
PMA/	NULL
PHA-	NULL
or	NULL
activation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
in	NULL
conjunction	NULL
with	NULL
the	NULL
promoter	NULL
deletion	NULL
studies	NULL
(	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
)	NULL
would	NULL
strongly	NULL
suggest	NULL
that	NULL
other	NULL
kB	NULL
binding	NULL
sites	NULL
(	NULL
namely	NULL
-	NULL
103	NULL
and	NULL
-11	NULL
)	NULL
are	NULL
important	NULL
for	NULL
transcriptional	NULL
activation	NULL
.	NULL

Recently	NULL
,	NULL
McElhinny	NULL
et	NULL
al	NULL
.	NULL

494	NULL
__	NULL
Egr-1	NULL
and	NULL
NF-KB	NULL
Control	NULL
T	NULL
Cell-activated	NULL
NF-BI	NULL
Transcription	NULL
(	NULL
22	NULL
)	NULL
demonstrated	NULL
that	NULL
the	NULL
-11	NULL
NF-KB	NULL
site	NULL
was	NULL
required	NULL
for	NULL
HIV-mediated	NULL
induction	NULL
of	NULL
promoter	NULL
in	NULL
mono-cytes	NULL
.	NULL

Although	NULL
the	NULL
-289	NULL
motif	NULL
is	NULL
probably	NULL
not	NULL
the	NULL
only	NULL
functional	NULL
NF-kB	NULL
motif	NULL
,	NULL
site-directed	NULL
mutagenesis	NULL
of	NULL
both	NULL
the	NULL
Egr-1	NULL
and	NULL
NF-KB	NULL
elements	NULL
(	NULL
mNELUC	NULL
)	NULL
,	NULL
resulted	NULL
in	NULL
a	NULL
further	NULL
decrease	NULL
in	NULL
PMA/	NULL
PH	NULL
A-responsive	NULL
stimulation	NULL
compared	NULL
to	NULL
the	NULL
mELUC	NULL
construct	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
)	NULL
.	NULL

Taking	NULL
into	NULL
account	NULL
that	NULL
mutagenesis	NULL
of	NULL
the	NULL
Egr-1	NULL
site	NULL
in	NULL
the	NULL
NF-kBI	NULL
promoter	NULL
significantly	NULL
diminished	NULL
PMA/PHA-responsive	NULL
stimulation	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
-68	NULL
Egr-1	NULL
site	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
this	NULL
gene	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

NF-kB	NULL
and	NULL
Egr-1	NULL
T	NULL
ransaiption	NULL
Synergistically	NULL
T	NULL
rans-activate	NULL
the	NULL
NF-KkBI	NULL
Promoter	NULL
.	NULL

To	NULL
further	NULL
explore	NULL
the	NULL
ability	NULL
of	NULL
each	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
to	NULL
activate	NULL
the	NULL
NF-kBI	NULL
promoter	NULL
,	NULL
the	NULL
wild-type	NULL
as	NULL
well	NULL
as	NULL
the	NULL
site-directed	NULL
mutant	NULL
reporters	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
empty	NULL
expression	NULL
plasmid	NULL
or	NULL
with	NULL
constructs	NULL
encoding	NULL
either	NULL
RelA	NULL
,	NULL
the	NULL
p65	NULL
subunit	NULL
of	NULL
NF-kB	NULL
,	NULL
Egr-1	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
both	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
,	NULL
the	NULL
SSLUC	NULL
reporter	NULL
was	NULL
strongly	NULL
transactivated	NULL
after	NULL
cotransfection	NULL
with	NULL
the	NULL
RelA	NULL
encoding	NULL
expression	NULL
construct	NULL
,	NULL
but	NULL
only	NULL
weakly	NULL
activated	NULL
by	NULL
the	NULL
overexpression	NULL
of	NULL
Egr-1	NULL
.	NULL

Interestingly	NULL
,	NULL
transfection	NULL
with	NULL
both	NULL
RelA	NULL
and	NULL
Egr-1	NULL
resulted	NULL
in	NULL
a	NULL
potent	NULL
synergistic	NULL
transactivation	NULL
of	NULL
the	NULL
NF-kBI	NULL
promoter	NULL
.	NULL

Although	NULL
the	NULL
-289	NULL
kB	NULL
site	NULL
was	NULL
important	NULL
for	NULL
R	NULL
elA-mediated	NULL
transacti-vation	NULL
,	NULL
mutagenesis	NULL
of	NULL
this	NULL
element	NULL
did	NULL
not	NULL
affect	NULL
activation	NULL
by	NULL
Egr-	NULL
1	NULL
,	NULL
nor	NULL
did	NULL
it	NULL
affect	NULL
RelA/	NULL
Egr-1	NULL
synergy	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
)	NULL
.	NULL

This	NULL
result	NULL
would	NULL
suggest	NULL
that	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Egr-1	NULL
binding	NULL
,	NULL
other	NULL
kB	NULL
sites	NULL
located	NULL
within	NULL
the	NULL
promoter	NULL
are	NULL
used	NULL
for	NULL
the	NULL
synergistic	NULL
response	NULL
.	NULL

Unlike	NULL
the	NULL
mNLUC	NULL
reporter	NULL
,	NULL
mutagenesis	NULL
of	NULL
the	NULL
Egr-1	NULL
site	NULL
(	NULL
mELUC	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
reduction	NULL
in	NULL
RelA-	NULL
,	NULL
Egrl-	NULL
,	NULL
and	NULL
RelA/Egr1-mediated	NULL
activation	NULL
of	NULL
the	NULL
NF-kBI	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
disruption	NULL
of	NULL
both	NULL
the	NULL
-289	NULL
and	NULL
-68	NULL
sites	NULL
(	NULL
mNELUC	NULL
)	NULL
did	NULL
not	NULL
further	NULL
diminish	NULL
RelA/	NULL
Egr-1-medi-ated	NULL
synergy	NULL
.	NULL

This	NULL
would	NULL
suggest	NULL
that	NULL
overexpression	NULL
of	NULL
both	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
may	NULL
indirectly	NULL
lead	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NF-kBI	NULL
promoter	NULL
by	NULL
upregulating	NULL
other	NULL
trans-acting	NULL
elements	NULL
,	NULL
or	NULL
that	NULL
Egr-1	NULL
(	NULL
like	NULL
NF-KB	NULL
)	NULL
recognizes	NULL
other	NULL
DNA-binding	NULL
sites	NULL
within	NULL
the	NULL
NF-	NULL
«	NULL
kBI	NULL
promoter	NULL
.	NULL

Collectively	NULL
,	NULL
co-transfection	NULL
studies	NULL
strongly	NULL
suggest	NULL
that	NULL
the	NULL
Egr-1	NULL
DNA	NULL
binding	NULL
site	NULL
is	NULL
critical	NULL
for	NULL
both	NULL
Egr-1-mediated	NULL
transactivation	NULL
and	NULL
for	NULL
R	NULL
elA/	NULL
Egr-1-dependent	NULL
synergy	NULL
.	NULL

Although	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
of	NULL
RelA	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
protein-protein	NULL
interactions	NULL
with	NULL
transcription	NULL
factors	NULL
outside	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
kB/	NULL
Rel	NULL
family	NULL
(	NULL
23-26	NULL
)	NULL
,	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
demonstrate	NULL
a	NULL
physical	NULL
interaction	NULL
between	NULL
RelA	NULL
and	NULL
Egr-1	NULL
,	NULL
nor	NULL
were	NULL
we	NULL
able	NULL
to	NULL
generate	NULL
synergistic	NULL
transactivation	NULL
mediated	NULL
by	NULL
these	NULL
factors	NULL
using	NULL
either	NULL
a	NULL
3	NULL
X-NF-kB	NULL
or	NULL
3	NULL
%	NULL
-Egr-1	NULL
CAT	NULL
reporter	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Egr-1	NULL
Complements	NULL
TNF-a	NULL
to	NULL
Stimulate	NULL
the	NULL
NF-kB1	NULL
Promoter	NULL
.	NULL

_	NULL
To	NULL
determine	NULL
whether	NULL
the	NULL
difference	NULL
between	NULL
PMA/	NULL
PHA-	NULL
and	NULL
TNF-o-stimulated	NULL
NF-BI	NULL
gene	NULL
expression	NULL
was	NULL
due	NULL
to	NULL
the	NULL
inability	NULL
of	NULL
TNF-a	NULL
to	NULL
activate	NULL
Egr-	NULL
1	NULL
,	NULL
CEM	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
SSLUC	NULL
reporter	NULL
along	NULL
with	NULL
the	NULL
495	NULL
_	NULL
Cogswell	NULL
et	NULL
al	NULL
.	NULL

empty	NULL
vector	NULL
control	NULL
or	NULL
with	NULL
the	NULL
Egr-1	NULL
expression	NULL
construct	NULL
and	NULL
24	NULL
h	NULL
later	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA/	NULL
PHA	NULL
or	NULL
TNF-	NULL
«	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
C	NULL
,	NULL
the	NULL
fold	NULL
increase	NULL
between	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
vector	NULL
control	NULL
or	NULL
with	NULL
the	NULL
Egr-1	NULL
expression	NULL
construct	NULL
was	NULL
comparable	NULL
to	NULL
previous	NULL
experiments	NULL
,	NULL
while	NULL
PMA/	NULL
PHA-stimulated	NULL
cells	NULL
(	NULL
coexpressing	NULL
Egr-1	NULL
)	NULL
displayed	NULL
the	NULL
highest	NULL
level	NULL
of	NULL
NF-kBI	NULL
activation	NULL
.	NULL

Interestingly	NULL
,	NULL
cells	NULL
transfected	NULL
with	NULL
Egr-1	NULL
and	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
displayed	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
promoter	NULL
activity	NULL
,	NULL
compared	NULL
to	NULL
TNF-o-stimulated	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
vector	NULL
control	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
Egr-1	NULL
to	NULL
augment	NULL
TNF-o-mediated	NULL
activation	NULL
of	NULL
the	NULL
promoter	NULL
was	NULL
a	NULL
direct	NULL
effect	NULL
since	NULL
the	NULL
transcriptional	NULL
synergy	NULL
was	NULL
not	NULL
observed	NULL
with	NULL
the	NULL
mELUC	NULL
construct	NULL
containing	NULL
the	NULL
dis	NULL
rupted	NULL
Egr-1	NULL
binding	NULL
site	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
the	NULL
Egr-1	NULL
transcription	NULL
factor	NULL
can	NULL
complement	NULL
TNF-a	NULL
«	NULL
-mediated	NULL
stimulation	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

Furthermore	NULL
,	NULL
our	NULL
data	NULL
suggests	NULL
that	NULL
the	NULL
inability	NULL
of	NULL
TNF-a	NULL
to	NULL
activate	NULL
Egr-1	NULL
may	NULL
account	NULL
for	NULL
the	NULL
difference	NULL
between	NULL
PMA/PHA-	NULL
and	NULL
TNF-o	NULL
«	NULL
-mediated	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Endogenous	NULL
NF-kBI1	NULL
Gene	NULL
Expression	NULL
Is	NULL
A	NULL
ffeaed	NULL
in	NULL
T	NULL
Cells	NULL
Expressing	NULL
Antisense	NULL
Egr-1	NULL
RNA	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
Egr-1	NULL
transcription	NULL
factor	NULL
on	NULL
endogenous	NULL
NF-kBI	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
developed	NULL
a	NULL
CEM	NULL
cell	NULL
line	NULL
which	NULL
constitutively	NULL
expressed	NULL
antisense	NULL
human	NULL
Egr-1	NULL
RNA	NULL
.	NULL

Total	NULL
RN	NULL
As	NULL
were	NULL
isolated	NULL
from	NULL
either	NULL
CEM/	NULL
AsEgr-1	NULL
cells	NULL
(	NULL
which	NULL
express	NULL
the	NULL
human	NULL
Egr-1	NULL
antisense	NULL
RNA	NULL
)	NULL
or	NULL
from	NULL
CEM/	NULL
CMV	NULL
control	NULL
cells	NULL
(	NULL
which	NULL
harbor	NULL
the	NULL
empty	NULL
expression	NULL
vector	NULL
)	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
either	NULL
PMA/PHA	NULL
or	NULL
TNF-a	NULL
over	NULL
the	NULL
time	NULL
course	NULL
indicated	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
,	NULL
CEM/	NULL
AsEgr-1	NULL
cells	NULL
did	NULL
not	NULL
display	NULL
significant	NULL
increases	NULL
in	NULL
NF-BI	NULL
transcripts	NULL
until	NULL
4	NULL
h	NULL
after	NULL
PMA/	NULL
PHA	NULL
addition	NULL
,	NULL
while	NULL
the	NULL
control	NULL
cells	NULL
(	NULL
CEM/CMV	NULL
)	NULL
responded	NULL
within	NULL
1	NULL
to	NULL
2	NULL
h	NULL
with	NULL
similar	NULL
kinetics	NULL
as	NULL
the	NULL
parental	NULL
CEM	NULL
cell	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
TNF-o-stimulated	NULL
CEM/	NULL
AsEgr-1	NULL
cells	NULL
demonstrated	NULL
a	NULL
reduction	NULL
in	NULL
NF-	NULL
«	NULL
kBI	NULL
transcripts	NULL
30	NULL
min	NULL
after	NULL
activation	NULL
.	NULL

Although	NULL
TNF-a	NULL
does	NULL
not	NULL
activate	NULL
Egr-1	NULL
,	NULL
it	NULL
would	NULL
appear	NULL
that	NULL
under	NULL
conditions	NULL
in	NULL
which	NULL
endogenous	NULL
Egr-1	NULL
levels	NULL
are	NULL
reduced	NULL
(	NULL
as	NULL
with	NULL
CEM/	NULL
AsEgr-1	NULL
cells	NULL
)	NULL
,	NULL
TNF-a	NULL
stimulation	NULL
represses	NULL
NF-KBI	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
level	NULL
of	NULL
Egr-1	NULL
protein	NULL
in	NULL
the	NULL
CEM/	NULL
AsEgr-1	NULL
cells	NULL
after	NULL
PMA/PHA	NULL
stimulation	NULL
was	NULL
significantly	NULL
lower	NULL
(	NULL
fivefold	NULL
)	NULL
than	NULL
protein	NULL
levels	NULL
observed	NULL
in	NULL
the	NULL
control	NULL
line	NULL
,	NULL
the	NULL
antisense	NULL
Egr-1	NULL
transcripts	NULL
were	NULL
not	NULL
able	NULL
to	NULL
completely	NULL
block	NULL
PMA/	NULL
PH	NULL
A-mediated	NULL
increases	NULL
in	NULL
Egr-1	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
)	NULL
.	NULL

Perhaps	NULL
for	NULL
this	NULL
reason	NULL
CEM/	NULL
AsEgr-1	NULL
cells	NULL
are	NULL
still	NULL
able	NULL
to	NULL
display	NULL
PMA/	NULL
PH	NULL
A-responsive	NULL
upregulation	NULL
of	NULL
NF-BI	NULL
transcripts	NULL
but	NULL
with	NULL
slower	NULL
kinetics	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
to	NULL
achieve	NULL
full	NULL
activation	NULL
of	NULL
the	NULL
NF-BI	NULL
promoter	NULL
,	NULL
T	NULL
cell	NULL
signals	NULL
require	NULL
not	NULL
only	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
,	NULL
but	NULL
also	NULL
the	NULL
Egr-1	NULL
transcription	NULL
factor	NULL
.	NULL

Interestingly	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
the	NULL
potent	NULL
activation	NULL
of	NULL
NF-kB	NULL
DN	NULL
A	NULL
binding	NULL
activity	NULL
by	NULL
TNF-a	NULL
is	NULL
insufficient	NULL
at	NULL
inducing	NULL
high	NULL
levels	NULL
of	NULL
transcription	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
recent	NULL
report	NULL
that	NULL
activation	NULL
of	NULL
NF-kB	NULL
binding	NULL
by	NULL
TNF-a	NULL
is	NULL
insufficient	NULL
at	NULL
activating	NULL
VCAM-1	NULL
A	NULL
CEM/CMV	NULL
CEM/AsEgr-1	NULL
.+	NULL
EMAPHA	NULL
(	NULL
h	NULL
}	NULL
||	NULL
£	NULL
TNF	NULL
(	NULL
D	NULL
)	NULL
1	NULL
|+	NULL
EMAiPHA	NULL
(	NULL
mu	NULL
£	NULL
ThE-	NULL
«	NULL
(	NULL
)	NULL
1	NULL
Figure	NULL
4	NULL
.	NULL

Egr-1	NULL
is	NULL
required	NULL
for	NULL
endoge-0	NULL
us	NULL
10	NULL
2	NULL
40	NULL
5	NULL
140	NULL
2	NULL
4	NULL
0	NULL
us	NULL
1	NULL
_	NULL
2	NULL
40	NULL
25	NULL
10	NULL
20	NULL
4	NULL
nous	NULL
NF-kBI	NULL
gene	NULL
expression	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Total	NULL
RNAs	NULL
were	NULL
isolated	NULL
from	NULL
CEM/CMV	NULL
o-	NULL
»	NULL
caa	NULL
wwe	NULL
anal	NULL
Tih	NULL
.	NULL

ugs	NULL
-	NULL
i	NULL
``	NULL
``	NULL
I	NULL
o	NULL
»	NULL
WBB	NULL
was	NULL
-G-	NULL
NF-xB1	NULL
control	NULL
cells	NULL
or	NULL
from	NULL
CEM/	NULL
AsEgr-1	NULL
cells	NULL
stimulated	NULL
with	NULL
either	NULL
PMA/PHA	NULL
or	NULL
B	NULL
TNF-a	NULL
over	NULL
a	NULL
4	NULL
h	NULL
period	NULL
.	NULL

RNAs	NULL
were	NULL
detected	NULL
using	NULL
a	NULL
P-labeled	NULL
NF-KBI	NULL
specific	NULL
CEM/CMV	NULL
CEM/AsEgr-	NULL
‘	NULL
I	NULL
probe	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Total	NULL
proteins	NULL
were	NULL
isolated	NULL
from	NULL
CEM/CMV	NULL
or	NULL
CEM/	NULL
AsEgr-1	NULL
cells	NULL
after	NULL
+	NULL
PMA/PHA	NULL
,	NULL
_+	NULL
TNF-a	NULL
_	NULL
+	NULL
PMA/PHA	NULL
,	NULL
+	NULL
TNF-a	NULL
_	NULL
the	NULL
addition	NULL
of	NULL
either	NULL
PMA/	NULL
PHA	NULL
or	NULL
TNF-	NULL
.	NULL

0	NULL
f	NULL
2	NULL
40	NULL
10	NULL
20	NULL
4	NULL
0	NULL
°	NULL
14	NULL
20	NULL
4	NULL
10	NULL
20	NULL
4	NULL
Proteins	NULL
were	NULL
subjected	NULL
to	NULL
PAGE	NULL
and	NULL
ana-ncurses	NULL
«	NULL
#	NULL
Eqgr-1	NULL
lyzed	NULL
using	NULL
an	NULL
Egr-1-specific	NULL
antibody	NULL
and	NULL
«	NULL
*	NULL
9	NULL
enhanced	NULL
chemiluminescent	NULL
assay	NULL
.	NULL

NS	NULL
,	NULL
shows	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
nonspecific	NULL
band	NULL
and	NULL
demonstrates	NULL
that	NULL
equal	NULL
amounts	NULL
of	NULL
protein	NULL
oe	NULL
wl	NULL
os	NULL
e	NULL
e	NULL
e	NULL
~-	NULL
.	NULL

``	NULL
_	NULL
``	NULL
oa	NULL
@	NULL
-	NULL
NS	NULL
were	NULL
loaded	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

transcription	NULL
in	NULL
some	NULL
cells	NULL
,	NULL
but	NULL
the	NULL
co-activation	NULL
of	NULL
NF-kB	NULL
and	NULL
IRF-1	NULL
in	NULL
endothelial	NULL
cells	NULL
functions	NULL
to	NULL
stimulate	NULL
transcription	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
like	NULL
NF-kB	NULL
,	NULL
Egr-1	NULL
is	NULL
a	NULL
relatively	NULL
poor	NULL
activator	NULL
of	NULL
NF-BI	NULL
transcription	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
the	NULL
combined	NULL
action	NULL
of	NULL
NF-kB	NULL
and	NULL
Egr-1	NULL
,	NULL
both	NULL
of	NULL
which	NULL
alone	NULL
result	NULL
in	NULL
weak	NULL
activation	NULL
,	NULL
that	NULL
functions	NULL
to	NULL
synergistically	NULL
stimulate	NULL
the	NULL
NF-B1	NULL
promoter	NULL
.	NULL

A	NULL
number	NULL
of	NULL
NFKB-responsive	NULL
genes	NULL
have	NULL
been	NULL
characterized	NULL
and	NULL
found	NULL
to	NULL
require	NULL
Egr-1	NULL
DNA	NULL
binding	NULL
motifs	NULL
for	NULL
maximum	NULL
transactivation	NULL
.	NULL

Such	NULL
genes	NULL
include	NULL
TNF-a	NULL
,	NULL
IL-2	NULL
,	NULL
and	NULL
ICAM-1	NULL
(	NULL
17	NULL
,	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
TNF-	NULL
«	NULL
does	NULL
not	NULL
fully	NULL
upregulate	NULL
its	NULL
own	NULL
promoter	NULL
,	NULL
presumably	NULL
because	NULL
of	NULL
the	NULL
inability	NULL
of	NULL
cytokines	NULL
to	NULL
activate	NULL
Egr-1	NULL
(	NULL
17	NULL
)	NULL
.	NULL

However	NULL
,	NULL
primary	NULL
human	NULL
fibroblasts	NULL
and	NULL
mac	NULL
rophage	NULL
cell	NULL
lines	NULL
display	NULL
dramatic	NULL
increases	NULL
in	NULL
Egr-1	NULL
after	NULL
TNF-a	NULL
stimulation	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
studies	NULL
would	NULL
suggest	NULL
that	NULL
the	NULL
synergistic	NULL
potential	NULL
mediated	NULL
by	NULL
the	NULL
NF-kB	NULL
and	NULL
Egr-1	NULL
transcription	NULL
factors	NULL
are	NULL
not	NULL
only	NULL
restricted	NULL
by	NULL
the	NULL
type	NULL
of	NULL
stimuli	NULL
,	NULL
but	NULL
also	NULL
may	NULL
depend	NULL
on	NULL
the	NULL
particular	NULL
cell	NULL
type	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
the	NULL
functional	NULL
interaction	NULL
of	NULL
NF-kB	NULL
and	NULL
Egr-1	NULL
in	NULL
the	NULL
context	NULL
of	NULL
a	NULL
promoter	NULL
is	NULL
likely	NULL
to	NULL
mediate	NULL
critical	NULL
aspects	NULL
of	NULL
T	NULL
cell	NULL
signaling	NULL
and	NULL
potentially	NULL
other	NULL
important	NULL
aspects	NULL
of	NULL
cellular	NULL
growth	NULL
control	NULL
.	NULL

The	NULL
potent	NULL
synergy	NULL
between	NULL
NF-kB	NULL
and	NULL
Egr-1	NULL
may	NULL
explain	NULL
,	NULL
at	NULL
least	NULL
partially	NULL
,	NULL
the	NULL
requirements	NULL
for	NULL
these	NULL
transcription	NULL
factors	NULL
in	NULL
T	NULL
cell	NULL
proliferation	NULL
with	NULL
NF-kBI	NULL
being	NULL
a	NULL
critical	NULL
downstream	NULL
target	NULL
for	NULL
Egr-1	NULL
.	NULL

We	NULL
would	NULL
like	NULL
to	NULL
thank	NULL
Dr.	NULL
Vikas	NULL
P.	NULL
Sukhatme	NULL
for	NULL
providing	NULL
the	NULL
human	NULL
Egr-1	NULL
cDNA	NULL
.	NULL

We	NULL
would	NULL
also	NULL
like	NULL
to	NULL
thank	NULL
S.	NULL
Scott	NULL
Drouin	NULL
for	NULL
technical	NULL
assistance	NULL
in	NULL
the	NULL
preparation	NULL
of	NULL
this	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
funded	NULL
by	NULL
the	NULL
National	NULL
Institute	NULL
of	NULL
Health	NULL
(	NULL
NIH	NULL
)	NULL
grant	NULL
AI35098	NULL
awarded	NULL
to	NULL
A.S	NULL
Baldwin	NULL
and	NULL
by	NULL
the	NULL
NIH	NULL
postdoctoral	NULL
fellowship	NULL
grant	NULL
1F32-CA69790-01	NULL
awarded	NULL
to	NULL
M.W	NULL
.	NULL

Mayo	NULL
.	NULL

Address	NULL
correspondence	NULL
to	NULL
Albert	NULL
S.	NULL
Baldwin	NULL
,	NULL
Lineberger	NULL
Comprehensive	NULL
Cancer	NULL
Center	NULL
,	NULL
Campus	NULL
Box	NULL
No	NULL
.	NULL

7295	NULL
,	NULL
University	NULL
of	NULL
North	NULL
Carolina	NULL
,	NULL
Chapel	NULL
Hill	NULL
,	NULL
NC	NULL
27599	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
20	NULL
September	NULL
1996	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
21	NULL
November	NULL
1996	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
and	NULL
T.	NULL
Henkel	NULL
.	NULL

1994	NULL
.	NULL

Function	NULL
and	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12	NULL
:	NULL
141-179	NULL
.	NULL

2	NULL
.	NULL

Baldwin	NULL
,	NULL
A.S.	NULL
1996	NULL
.	NULL

The	NULL
NF-KB	NULL
and	NULL
IB	NULL
proteins	NULL
:	NULL
new	NULL
discoveries	NULL
and	NULL
insights	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:649-681	NULL
.	NULL

3	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.A	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
inducible	NULL
transcription	NULL
activator	NULL
NF-KB	NULL
:	NULL
regulation	NULL
by	NULL
distinct	NULL
protein	NULL
subunits	NULL
.	NULL

Biochim	NULL
.	NULL

Bio	NULL
phys	NULL
.	NULL

Aaa	NULL
.	NULL

1072:63-80	NULL
.	NULL

4	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

IB	NULL
:	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
NF-KB	NULL
transcription	NULL
factor	NULL
.	NULL

(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

242:540-546	NULL
.	NULL

5	NULL
.	NULL

MacKichan	NULL
,	NULL
M.L	NULL
.	NULL

,	NULL
F.	NULL
Logeat	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1996	NULL
.	NULL

Phosphorylation	NULL
of	NULL
p105	NULL
PEST	NULL
sequence	NULL
via	NULL
a	NULL
redox-insensitive	NULL
pathway	NULL
up-regulates	NULL
processing	NULL
to	NULL
p50	NULL
NF-kB	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

496	NULL
270:18347-18351	NULL
.	NULL

6	NULL
.	NULL

Palombella	NULL
,	NULL
V.J	NULL
.	NULL

,	NULL
O	NULL
.J	NULL
.	NULL

Rando	NULL
,	NULL
A.L	NULL
.	NULL

Goldberg	NULL
,	NULL
and	NULL
T.	NULL
Mania	NULL
tis	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
ubiquitin-proteasome	NULL
pathway	NULL
is	NULL
regulated	NULL
for	NULL
processing	NULL
the	NULL
NF-KB	NULL
precursor	NULL
protein	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
.	NULL

Cell	NULL
.	NULL

78:773-785	NULL
.	NULL

7	NULL
.	NULL

Chen	NULL
,	NULL
Z.J	NULL
.	NULL

,	NULL
J.	NULL
Hagler	NULL
,	NULL
V.J	NULL
.	NULL

Palombella	NULL
,	NULL
F.	NULL
Melandri	NULL
,	NULL
D.	NULL
Scherer	NULL
,	NULL
D.	NULL
Ballard	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
1995	NULL
.	NULL

Signal-induced	NULL
site-specific	NULL
phosphorylation	NULL
targets	NULL
IkBa	NULL
«	NULL
to	NULL
the	NULL
ubiquitin-proteasome	NULL
pathway	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:1586-1597	NULL
.	NULL

8	NULL
.	NULL

Rice	NULL
,	NULL
N.R	NULL
.	NULL

,	NULL
M.L	NULL
.	NULL

MacKichan	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
precursor	NULL
of	NULL
NF-kB	NULL
p50	NULL
has	NULL
IKB-like	NULL
functions	NULL
.	NULL

Cel	NULL
.	NULL

71:243-253	NULL
.	NULL

9	NULL
.	NULL

Costello	NULL
,	NULL
R.	NULL
,	NULL
C.	NULL
Cerdan	NULL
,	NULL
C.	NULL
Lipcey	NULL
,	NULL
M.	NULL
Algarte	NULL
,	NULL
Y.	NULL
Martin	NULL
,	NULL
P.A	NULL
.	NULL

Bacuerle	NULL
,	NULL
D.	NULL
Olive	NULL
,	NULL
and	NULL
J.	NULL
Imbert	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
B1	NULL
(	NULL
p50/	NULL
p105	NULL
)	NULL
gene	NULL
expression	NULL
in	NULL
activation	NULL
of	NULL
human	NULL
Egr-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
Control	NULL
T	NULL
Cell-activated	NULL
NF-BI	NULL
Transcription	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20.	NULL
blood	NULL
T-lymphocytes	NULL
via	NULL
CD2	NULL
and	NULL
CD28	NULL
adhesion	NULL
mole-cules	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

4:947-954	NULL
.	NULL

Sha	NULL
,	NULL
W.C.	NULL
,	NULL
H.-C.	NULL
Liou	NULL
,	NULL
EI	NULL
.	NULL

Tuomanen	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1995	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-KB	NULL
leads	NULL
to	NULL
multifocal	NULL
defects	NULL
in	NULL
immune	NULL
responses	NULL
.	NULL

Cell	NULL
.	NULL

80:321-330	NULL
.	NULL

Cogswell	NULL
,	NULL
P.C	NULL
.	NULL

,	NULL
R	NULL
.I	NULL
.	NULL

Scheinman	NULL
,	NULL
and	NULL
A.S.	NULL
Baldwin	NULL
.	NULL

1993	NULL
.	NULL

Promoter	NULL
of	NULL
the	NULL
human	NULL
NF-kB	NULL
p50/p105	NULL
gene	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

150:2794-2804	NULL
.	NULL

Ten	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
C.V.	NULL
Paya	NULL
,	NULL
N.	NULL
Israel	NULL
,	NULL
O.	NULL
LeBail	NULL
,	NULL
M.-G.	NULL
Mattei	NULL
,	NULL
J.-L.	NULL
Virelizier	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
characterization	NULL
of	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-KB	NULL
indicates	NULL
that	NULL
it	NULL
participates	NULL
in	NULL
its	NULL
own	NULL
regula-tion	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

11:195-203	NULL
.	NULL

Meyer	NULL
,	NULL
R.	NULL
,	NULL
H.-P.	NULL
Hatada	NULL
,	NULL
H.-P.	NULL
Hohmann	NULL
,	NULL
M.	NULL
Haiker	NULL
,	NULL
C.	NULL
Bartsch	NULL
,	NULL
U.	NULL
Rotlisbperger	NULL
,	NULL
H.-W.	NULL
Lahm	NULL
,	NULL
E.J	NULL
.	NULL

Schlaeger	NULL
,	NULL
A.P.G.M	NULL
.	NULL

vanLoon	NULL
,	NULL
and	NULL
C.	NULL
Scheidereit	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
DNA-binding	NULL
subunit	NULL
of	NULL
human	NULL
nuclear	NULL
factor	NULL
KB	NULL
:	NULL
the	NULL
level	NULL
of	NULL
its	NULL
mRNA	NULL
is	NULL
strongly	NULL
regulated	NULL
by	NULL
phorbol	NULL
ester	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a.	NULL
Proc	NULL
Natl	NULL
.	NULL

Aad	NULL
.	NULL

Sa	NULL
.	NULL

USA	NULL
.	NULL

8	NULL
$	NULL
8:966-970	NULL
.	NULL

Hohmann	NULL
,	NULL
H.-P.	NULL
,	NULL
R.	NULL
Remmy	NULL
,	NULL
C.	NULL
Scheidereit	NULL
,	NULL
and	NULL
A.P.G.M	NULL
.	NULL

vanLoon	NULL
.	NULL

1991	NULL
.	NULL

Maintenance	NULL
of	NULL
NF-KB	NULL
activity	NULL
is	NULL
dependent	NULL
on	NULL
protein	NULL
synthesis	NULL
and	NULL
the	NULL
continuous	NULL
presence	NULL
of	NULL
external	NULL
stimuli	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
.	NULL

11:259-266	NULL
.	NULL

Gashler	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
V.P	NULL
.	NULL

Sukhatme	NULL
.	NULL

1995	NULL
.	NULL

Early	NULL
growth	NULL
response	NULL
protein	NULL
1	NULL
(	NULL
Egr-1	NULL
)	NULL
:	NULL
prototype	NULL
of	NULL
a	NULL
zinc-finger	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Prog	NULL
NudeicAdad	NULL
Res	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

50:191-224	NULL
.	NULL

Perez-Castillo	NULL
,	NULL
A.	NULL
,	NULL
C.	NULL
Pipaon	NULL
,	NULL
I.	NULL
Garcia	NULL
,	NULL
and	NULL
S.	NULL
Alemany	NULL
.	NULL

1993	NULL
.	NULL

NGFI-A	NULL
gene	NULL
expression	NULL
is	NULL
necessary	NULL
for	NULL
T	NULL
lympho-cyte	NULL
proliferation	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:19445-19450	NULL
.	NULL

Kramer	NULL
,	NULL
B.	NULL
,	NULL
A.	NULL
Meichle	NULL
,	NULL
G.	NULL
Hensel	NULL
,	NULL
P.	NULL
Charnay	NULL
,	NULL
and	NULL
M.	NULL
Kronke	NULL
.	NULL

1994	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
Krox-24/Egr-1-response	NULL
element	NULL
in	NULL
the	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
promoter	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Aaa	NULL
.	NULL

1219:413-421	NULL
.	NULL

Finco	NULL
,	NULL
TS	NULL
.	NULL

,	NULL
and	NULL
A.S.	NULL
Baldwin	NULL
.	NULL

1993	NULL
.	NULL

KB	NULL
site-dependent	NULL
induction	NULL
of	NULL
gene	NULL
expression	NULL
by	NULL
diverse	NULL
inducers	NULL
of	NULL
NF-KB	NULL
requires	NULL
Raf	NULL
1	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:676-679	NULL
.	NULL

Gilman	NULL
,	NULL
M.Z	NULL
.	NULL

,	NULL
R.N	NULL
.	NULL

Wilson	NULL
,	NULL
and	NULL
R.A.	NULL
Weinberg	NULL
.	NULL

1986	NULL
.	NULL

Multiple	NULL
protein-binding	NULL
sites	NULL
in	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
regulate	NULL
c-fos	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

6:4305-4316	NULL
.	NULL

Higuchi	NULL
,	NULL
R.	NULL
,	NULL
G.	NULL
Krummel	NULL
,	NULL
and	NULL
R.	NULL
Saiki	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
general	NULL
method	NULL
of	NULL
in	NULL
vitro	NULL
preparation	NULL
and	NULL
specific	NULL
mutagenesis	NULL
of	NULL
497	NULL
__	NULL
Cogswell	NULL
et	NULL
al	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

DNA	NULL
fragments	NULL
:	NULL
study	NULL
of	NULL
protein	NULL
and	NULL
DN	NULL
A	NULL
interactions	NULL
.	NULL

Nu-deic	NULL
A	NULL
ads	NULL
Res	NULL
.	NULL

16:7351-7367	NULL
.	NULL

Bravo	NULL
,	NULL
R	NULL
.	NULL

1990	NULL
.	NULL

Growth	NULL
factor	NULL
inducible	NULL
genes	NULL
in	NULL
fibroblasts	NULL
.	NULL

In	NULL
Growth	NULL
Factors	NULL
,	NULL
Differentiation	NULL
Factors	NULL
and	NULL
Cytokines	NULL
.	NULL

A.	NULL
Habenich	NULL
,	NULL
editor	NULL
.	NULL

Springer-	NULL
Verlag	NULL
,	NULL
Berlin	NULL
.	NULL

324-343	NULL
.	NULL

McElhinny	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
W.S	NULL
.	NULL

MacMorran	NULL
,	NULL
G.D.	NULL
Bren	NULL
,	NULL
R.M	NULL
.	NULL

Ten	NULL
,	NULL
A.	NULL
Israel	NULL
,	NULL
and	NULL
C.V.	NULL
Paya	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
IB	NULL
and	NULL
p105	NULL
in	NULL
monocytes	NULL
and	NULL
macrophages	NULL
persistently	NULL
infected	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

J	NULL
Virol	NULL
69:1500-1509	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
P.C	NULL
.	NULL

Cogswell	NULL
,	NULL
and	NULL
A.S.	NULL
Baldwin	NULL
.	NULL

1993	NULL
.	NULL

Functional	NULL
and	NULL
physical	NULL
association	NULL
between	NULL
NF-kappa	NULL
B	NULL
and	NULL
C/EBP	NULL
family	NULL
members	NULL
:	NULL
a	NULL
Rel	NULL
domain-pZIP	NULL
interaction	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3964-3974	NULL
.	NULL

Diehl	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
M.	NULL
Hannink	NULL
.	NULL

1994	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
C/	NULL
EBP-Rel	NULL
complex	NULL
in	NULL
avian	NULL
lymphoid	NULL
cells	NULL
Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
14	NULL
:	NULL
6635-6646	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
,	NULL
A.	NULL
Agranoff	NULL
,	NULL
E.	NULL
Pascal	NULL
,	NULL
and	NULL
G.	NULL
Nabel	NULL
.	NULL

1994	NULL
.	NULL

An	NULL
interaction	NULL
between	NULL
the	NULL
DNA	NULL
binding	NULL
domains	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
and	NULL
Spl	NULL
mediates	NULL
HIV	NULL
gene	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

14:6570-6583	NULL
.	NULL

John	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
Reeves	NULL
,	NULL
J.	NULL
Lin	NULL
,	NULL
R.	NULL
Child	NULL
,	NULL
J.	NULL
Leiden	NULL
,	NULL
C.	NULL
Thomp-son	NULL
,	NULL
and	NULL
W.	NULL
Leonard	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
cell	NULL
type	NULL
specific	NULL
IL-2	NULL
receptor	NULL
«	NULL
chain	NULL
gene	NULL
expression	NULL
:	NULL
potential	NULL
role	NULL
of	NULL
physical	NULL
interaction	NULL
between	NULL
Elf	NULL
1	NULL
,	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
and	NULL
NF-KB	NULL
family	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

15:1786-1796	NULL
.	NULL

Ahmad	NULL
,	NULL
M.	NULL
,	NULL
N.	NULL
Marui	NULL
,	NULL
R.	NULL
Alexander	NULL
,	NULL
and	NULL
R.	NULL
Medford	NULL
.	NULL

1995	NULL
.	NULL

Cell	NULL
type-specific	NULL
transactivation	NULL
of	NULL
the	NULL
VCAM-1	NULL
promoter	NULL
through	NULL
an	NULL
NF-kB	NULL
enhancer	NULL
motif	NULL
.	NULL

J	NULL
Bio	NULL
!	NULL

Chen	NULL
.	NULL

270	NULL
:	NULL
8976-8983	NULL
.	NULL

Neish	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Read	NULL
,	NULL
D.	NULL
Thanos	NULL
,	NULL
R	NULL
.	NULL

Pine	NULL
,	NULL
T.	NULL
Maniatis	NULL
,	NULL
and	NULL
T.	NULL
Collins	NULL
1995	NULL
.	NULL

Endothelial	NULL
interferon	NULL
regulatory	NULL
factor	NULL
1	NULL
cooperates	NULL
with	NULL
NF-KB	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
of	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule	NULL
1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

15:2558-2569	NULL
.	NULL

Skerka	NULL
,	NULL
C.	NULL
,	NULL
EL	NULL
.	NULL

Decker	NULL
,	NULL
and	NULL
P.F	NULL
.	NULL

Zipfel	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
regulatory	NULL
element	NULL
in	NULL
the	NULL
human	NULL
interleukin	NULL
2	NULL
gene	NULL
promoter	NULL
is	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
zinc	NULL
finger	NULL
proteins	NULL
Spl	NULL
and	NULL
EGR	NULL
J	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:22500-22506	NULL
.	NULL

Maltzman	NULL
,	NULL
J.S	NULL
.	NULL

,	NULL
J.A	NULL
.	NULL

Carman	NULL
,	NULL
and	NULL
J.G	NULL
.	NULL

Monroe	NULL
.	NULL

1996	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
ICAM-1	NULL
gene	NULL
in	NULL
antigen	NULL
receptor	NULL
and	NULL
phorbol	NULL
ester	NULL
stimulated	NULL
B	NULL
lymphocytes	NULL
:	NULL
role	NULL
for	NULL
transcriptional	NULL
factor	NULL
Egr-1	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183:1747-1759	NULL
.	NULL

